2024 Virtual Grand Rounds
2024 Virtual Grand Rounds Session 7: May 8, 2024 - 60 Tips in 60 Minutes
About
Fall Clinical Virtual Grand Rounds consist of regularly scheduled CME sessions on a variety of dermatological diseases, delivered by the top experts in dermatology. Please join us for this week's session:
Wednesday, May 8, 2024
8 PM ET / 5 PM PT
60 Tips in 60 Minutes - Learn Clinical Tips You Can Incorporate into Your Practice Tomorrow!
Hear about tips and pearls for Acne, Alopecia, Atopic Dermatitis, Pediatric Dermatology, Practice Management and Office Tips, Vitiligo and more!
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
May 9, 2024
May 9, 2025
Learning Objectives
At the completion of this activity, participants should be better able to:
Enhance your ability to diagnose, manage, and treat with the most current treatment options
Identify patients who may benefit from new approaches to difficult to manage diseases
Apply best practices for enhancing patient communication and shared decision-making techniques
Decipher clinical trial data and guidelines and how to apply them to every day practice
Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
Whitney High, MD, JD, MEng
Associate Professor of Dermatology & Pathology
University of Colorado School of Medicine
Aurora, CO
Sandra Lee, MD
Dermatologist
Skinphysicians and surgeons
Dr. Pimple Popper
Upland, CA
Natasha Mesinkovska, MD, PhD
Vice Chair, Clinical Research
University of California Irvine
Irvine, CA
Daniel Siegel, MD, MS
Clinical Professor of Dermatology
SUNY Downstate Health Sciences University
New York, NY
Linda Stein Gold, MD
Director Clinical Research
Henry Ford Health System
Detroit, MI
Lisa Swanson, MD
Pediatric Dermatologist
Ada West Dermatology
Boise, ID
Susan Taylor, MD
Bernett L. Johnson Endowed Professor
Director, Skin of Color Research Fellowship
Vice Chair for Diversity, Equity and Inclusion, Department of Dermatology
Perelman School of Medicine at the University of Pennsylvania
Founder, Skin of Color Society
Philadelphia, PA
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
No relevant financial relationships with any Ineligible Company in the past 24 months.
Other Relationships: Spokesperson - SUN Pharma
Advisory Board: Pfizer, Lilly, Concert, Abbvie, Galderma
Grant/Research Support: Pfizer
Consultant: National Alopecia Areata Foundation
Speakers’ Bureau or Honoraria: Lilly
Employment by Ineligible Entity: SPC Dermatology
Advisory Board: Avita, Cara Therapeutics, Greenway Therapeutix, Modernizing Medicine, MycoMedica Life Sciences, SkinVision, Tetros Group,
Grant/Research Support: Regeneron,
Consultant: Avita, Feldan Therapeutics, Lazarus Enterprises Inc., Logical Images, Medforce Technologies, Inc., Pulse Biosciences, SciBASE, Seaspire Skincare, Strata Skin Sciences, Verrica Pharmaceuticals Inc
Speakers Bureau or Honoraria: Avita, Cara Therapeutics, Regeneron, Sanofi Genzyme,
Royalty: Biofrontera AG, Caliber Imaging and Diagnostics Inc., Elsevier Inc., Greenway Therapeutix, Novascan, Or-Genix, Therapeutics, Plasmend,
Intellectual Property Rights: Elsevier Inc., RaMedical,
Ownership Interest (privately held): SkinVision, Seaspireskincare, OrGenix
Grant/Research Support: Arcutis, BMS, Incyte, Dermavant, Galderma, Lilly, AbbVie
Consultant: Arcutis, BMS, Incyte, Dermavant, Galderma, Lilly, AbbVie
Speakers’ Bureau or Honoraria: Leo, AbbVie, Almirall, Galderma, Pfizer, Sanofi, Regeneron
Consultant: Janssen, Lilly, Ortho Dermatologics, Sanofi-Regeneron, Pfizer, LEO, Novan, Arcutis
Speakers’ Bureau or Honoraria: Ortho Dermatologics, Pfizer, Amgen, Sanofi-Regeneron, Almirall, Janssen, Lilly, Novartis, Abbvie, Incyte
Advisory Board: AbbVie, Avita Medical, Beiersdorf, Biorez (past), Eli Lilly, EPI Health, Evolus, Galderma, Hugel America, Incyte, Johnson & Johnson, L'Oreal USA, Medscape, Pfizer, Scientis US, UCB, Vichy Laboratoires Grant/Research Support: Allergan Aesthetics, Concert Pharmaceuticals/Sun Pharma, Croma Pharma GmbH, Eli Lilly, Pfizer Consultant: Arcutis, Armis Scientific, Beiersdorf, Bristol Myers Squibb, Cara Therapeutics, Dior, GloGetter, Piction Health, Sanofi Speakers’ Bureau or Honoraria: Beiersdorf, Medscape, MJH Lifesciences Royalty: McGraw Hill Publishing Ownership Interest (privately held): Armis Scientific, GloGetter, Piction Health Other Financial Benefit: Mercer Strategies LLC
The Institute discloses that all relevant conflicts have been satisfactorily mitigated.